Celadon Pharmaceuticals raises £2.1m for working capital
10th May 2024 11:48
(Sharecast News) - Medical cannabis specialist Celadon Pharmaceuticals announced on Friday that it has raised £2.1m to provide it with additional working capital.
Read moreCeladon starts supplying cannabis for two contracts
14th Dec 2023 11:16
(Sharecast News) - Medical cannabis specialist Celadon Pharmaceuticals has started supplying its pharmaceutical-grade product to two commercial contracts, first announced on 24 May and 5 September, it said on Thursday.
Read moreCeladon's new finance chief to join later in January
13th Jan 2023 13:24
(Sharecast News) - Celadon Pharmaceuticals updated the market on the arrival of its new finance chief on Friday.
Read moreCeladon confident in approval for its cannabis medicine facility
22nd Dec 2022 14:50
(Sharecast News) - Cannabis-based medicine developer Celadon Pharmaceuticals updated the market on its application for registration of its West Midlands facility with the UK Medicines and Healthcare products Regulatory Agency (MHRA) for the 'Good Manufacturing Practices' (GMP) approval of its cannabis active pharmaceutical ingredient (API).
Read moreSummerway to buy medicinal cannabis group Vertigrow
28th Oct 2021 10:10
(Sharecast News) - Summerway Capital has agreed to buy Vertigrow Technology, a medicinal cannabis producer, for £80m to take the business public and expand it.
Read moreCaparo Energy obtains first phase of financing
20th Jun 2011 15:01
Caparo Energy has today disclosed that it has obtained a first round of financing, for Rs 3,500m (US$78.5m), from the India Infrastructure Fund. The mezzanine debt takes the form of preference shares with a six year term. Of note, the company has highlighted the non-dilutive nature of these prefer
Read moreCaparo Energy finalises debt facility
30th Dec 2010 10:05
India-focused wind power generation investor Caparo Energy unveiled a $0.44m loss in its first set of interim results since listing on AIM in November. The company has yet to make its first set of investments but remains in discussion with Suzlon Energy regarding the roll out schedule or the first
Read moreCaparo raises £50.2m in AIM float
12th Oct 2010 17:52
India-focused wind power generation investor Caparo Energy has joined AIM today after a £50.2m fund raising. The net proceeds of the placing at 115p a share were £46.3m. The cash will be spent on purchasing existing projects from Suzlon Energy and to provide working capital. The acquisition of fur
Read moreCelsis gets 232.5p cash offer
3rd Aug 2009 09:02
Diagnostics group Celsis has agreed to a cash offer worth 232.5p per share or £54.5m in total from private equity group North Atlantic Value. Celsis directors have recommended the offer. 'We see this offer of 232.5p as an excellent opportunity for Celsis Shareholders to realise the value of their C
Read moreLondon close: Rally continues
21st Jul 2009 16:44
Footsie finished just shy of the 4,500 mark after another day of gains as the rally continues. Wm Morrison led the way after saying it is confident full year results will be ahead of its earlier expectations due to continuing customer growth and the successful implementation of its cost cutting pla
Read moreLondon afternoon: Advance gathers speed
21st Jul 2009 14:11
London kicked on over the lunchtime session, with risers outnumbering fallers by four to one among FTSE 100 constituents. Wm Morrison leads the way after saying it is confident full year results will be ahead of its earlier expectations due to continuing customer growth and the successful implement
Read moreLondon midday: Morrisons leads advance
21st Jul 2009 11:57
Retail stocks dominate proceedings in London following trading updates from Morrisons and Next. Wm Morrison leads the risers in the FTSE 100 after saying it is confident full year results will be ahead of its earlier expectations due to continuing customer growth and the successful implementation o
Read moreCelsis hit by sales slowdown
21st Jul 2009 07:51
Shares in Celsis tumbled as the biotech warned its two core businesses have slowed down in the first three months of the current year. The diagnostics kits Rapid Detection arm had a slow start to the quarter, but has regained momentum in June with strong instrument sales. However, trading results y
Read moreRestructuring lift Celsis
24th Jun 2009 07:54
Diagnostics group Celsis lifted profits by over 20% last year as better margins offset a mixed sales performance. Revenues were flat at $52.5m as a strong scond half at the rapid detection business offset declines at In Vitro Technologies and Analytical Services. Operating profit increased 17.9% t
Read more